Evidence map›Paper›PMID 40817260›Full record

ArticleTranslational psychiatry2025

Lipidomic and proteomic insights from extracellular vesicles in the postmortem dorsolateral prefrontal cortex reveal substance use disorder-induced brain changes.

Chioma M Okeoma, Wasifa Naushad, Bryson C Okeoma, Carlos Gartner, Yulica Santos-Ortega, Calvin Vary, Savio Lima-Bastos, Victor Corasolla Carregari, Martin R Larsen, Alessio Noghero and 2 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Chioma M OkeomaDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, USA. cokeoma@nymc.edu.ORCID http://orcid.org/0000-0001-7737-6493
Wasifa NaushadDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, USA.ORCID http://orcid.org/0000-0002-2375-082X
Bryson C OkeomaDepartment of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY, USA.ORCID http://orcid.org/0000-0002-6844-1035
Carlos GartnerMaine Health Institute for Research, Scarborough, ME, USA.
Yulica Santos-OrtegaMaine Health Institute for Research, Scarborough, ME, USA.
Calvin VaryMaine Health Institute for Research, Scarborough, ME, USA.
Savio Lima-BastosTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Victor Corasolla CarregariDepartment of Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Martin R LarsenDepartment of Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Alessio NogheroLovelace Biomedical Institute, Albuquerque, NM, USA.
Consuelo Walss-BassLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA. consuelo.walssbass@uth.tmc.edu.
Rodrigo Grassi-OliveiraTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. rogo@clin.au.dk.ORCID http://orcid.org/0000-0001-9911-5921

Funding

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI Susan L SANTANGELO · 2017 to 2026
$51.6M
Cannabinoid modulation of EV composition and function in HIV/SIV infectionR01DA050169 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI MOHAN, MAHESH, OKEOMA, CHIOMA M · 2019 to 2023
$3.8M
Gene-environment interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Coccaine AddictionR01DA044859 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GRASSI-OLIVEIRA, RODRIGO, SCHMITZ, JOY MARIE · 2017 to 2021
$2.8M
The effect of HIV and cocaine abuse on semen exosome composition and functionR01DA042348 · NIDA · UNIVERSITY OF IOWA · PI OKEOMA, CHIOMA M · 2016 to 2020
$2.7M
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.R33DA053643 · NIDA · NEW YORK MEDICAL COLLEGE · PI Mahesh Mohan, Chioma M Okeoma · 2023 to 2026
$1.3M
Det Frie Forskningsråd (Danish Council for Independent Research) 3166-00139BMinistry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 402503/2023-6NIDA NIH HHS R01 DA042348NIDA NIH HHS R01 DA044859NIDA NIH HHS R01 DA050169NIDA NIH HHS R33 DA053643NIGMS NIH HHS U54 GM115516U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DA042348U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DA050169U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21/R33DA053643U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA044859
6 · The paper itself

Abstract

Substance use disorder (SUD) significantly increases the risk of neurotoxicity, inflammation, oxidative stress, and impaired neuroplasticity. The activation of inflammatory pathways by substances may lead to reactive astrogliosis and chronic neuroinflammation, potentially mediated by the release of extracellular particles (EPs), such as extracellular condensates (ECs) and extracellular vesicles (EVs). These particles, which reflect the physiological, pathophysiological, and metabolic states of their cells of origin, might carry molecular signatures indicative of SUD. In particular, our study investigated neuroinflammatory signatures in SUD patients by isolating EVs from the dorsolateral prefrontal cortex (dlPFC) Brodmann's area 9 (BA9) from postmortem subjects. We isolated BA9-derived EVs from postmortem brain tissues of eight individuals (controls: n = 4, SUD: n = 4). The physical properties (concentration, size, zeta potential, morphology) of the EVs were analyzed, and the EVs were subjected to integrative multiomics analysis to profile the lipidomic and proteomic characteristics. We assessed the interactions and bioactivity of EVs by evaluating their uptake by glial cells. We further assessed the effects of EVs on complement mRNA expression in glial cells and on microglial migration. No significant differences in EV concentration, size, zeta potential, or surface markers were observed between the SUD group and the control group. However, lipidomic analysis revealed significant enrichment of glycerophosphoinositol bisphosphate (PIP2) in SUD-derived EVs. Proteomic analysis revealed the downregulation of SERPINB12, ACYP2, CAMK1D, DSC1, and FLNB and the upregulation of C4A, C3, and ALB in SUD-derived EVs. Gene Ontology (GO) and protein‒protein interactome analyses revealed functions associated with the identified proteins, such as cell motility, focal adhesion, and acute phase response signaling. Both control and SUD-derived EVs increased C3 and C4 mRNA expression in microglia, but only SUD-derived EVs upregulated these genes in astrocytes. SUD-EVs also significantly enhanced microglial migration in a wound healing assay. This study successfully isolated EVs from postmortem brains and used a multiomics approach to identify EV-associated lipids and proteins in SUD. Elevated C3 and C4 in SUD-derived EVs and the distinct effects of EVs on glial cells suggest a crucial role for these cells in acute phase response signaling and neuroinflammation.

Indexed as

Extracellular VesiclesPrefrontal CortexSubstance-Related DisordersAdultAgedAutopsyFemaleHumansLipidomicsMaleMicrogliaMiddle AgedNeurogliaProteomics

Identifiers

PMID40817260
PMCPMC12356847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.